Back to journals
Academic Journal

Current Neuropharmacology

4 Papers Indexed in Blossom

Data updated

Research Footprint

Current Neuropharmacology has 4 tracked papers indexed in Blossom (2014–2021) from 16 authors, most often covering MDMA, Ayahuasca and LSD, across Autism Spectrum Disorder (ASD), Interpersonal Functioning & Social Connectedness and Medicinal Chemistry & Drug Development.

Published Papers

Paywallmeta

A Systematic Review of the MDMA Model to Address Social Impairment in Autism

This systematic review finds that postnatal MDMA administration produces prosocial behaviours and may alleviate social impairments in autism models, with the strongest evidence coming from animal studies. Clinical trials are now under way, but larger and longer studies are needed to confirm whether MDMA or MDMA-like compounds can treat social deficits in ASD.

Published
Journal
Current Neuropharmacology
Authors
Chaliha, D., Mamo, J. C., Albrecht, M., Lam, V., Takechi, R., Vaccarezza, M.
Open Accessmeta

Dreams and psychedelics: neurophenomenological comparison and therapeutic implications

This review (2017) studied research literature on psychedelics and dreaming to systematically compare these two states of consciousness. It highlighted the broad overlap between dreaming and psychedelic states supporting the perception that psychedelics acutely affect dreamlike subjective experiences that may show long-term beneficial responses to psychosocial functioning and well-being.

Published
Journal
Current Neuropharmacology
Authors
Kraehenmann, R.
Open Accessmeta

Recreational Use, Analysis and Toxicity of Tryptamines

This comprehensive review (2015) summarizes the chemical characterization, pharmacology, and toxicity of New Psychoactive Substances from the published literature, as well as information gathered from non-peer-reviewed sources, such as drug forums. They provide an overview of useful information, such as reported death cases, for public health workers.

Published
Journal
Current Neuropharmacology
Authors
Tittarelli, R., Mannocchi, G., Pantano, F., Saverio Romolo, F.
Open Accessmeta

The role of ketamine in treatment-resistant depression: a systematic review

This review (24 studies; n=416) found that ketamine is a reliable fast-acting anti-depressant for patients suffering from treatment-resistant depression (TRD). Long-term effects, however, remain to be studied.

Published
Journal
Current Neuropharmacology
Authors
Serafini, G., Howland, R. H., Rovedi, F., Girardi, P., Amore, M.

Quick Facts

Papers Indexed
4
h-Index
112
Open Access
No
Publisher
Bentham Science Publishers
Country
United Arab Emirates
Website
Visit